It is a pharma private limited company based in Kollam, Kerala, India, established in 2018.
2018 | Kollam, Kerala, India | Struck OffNafata 360 Pharma International Private Limited, a struck off private limited company, was established on 23 January 2018 in Kollam, Kerala, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909KL2018PTC051891. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Nazarudeen Ebrahimkutty (Director), Fathahudeen (Director). It holds no open charges and ₹1.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 19/86, Al Jood Kottiyam Po, Kollam, Kerala, 691571.
U51909KL2018PTC051891
051891
23 January 2018
₹1.00 M
₹1.00 M
Roc Ernakulam
Unlisted
Struck Off
Explore comprehensive insights into Nafata 360 Pharma International Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nazarudeen Ebrahimkutty | Director | 23 Jan 2018 | Current |
| Fathahudeen | Director | 23 Jan 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nafata 360 Pharma International Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 36.77% decrease. The company also saw a substantial fall in profitability, with a 299.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 3395.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nafata 360 Pharma International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2018 | Canara Bank | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nafata 360 Pharma International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nafata 360 Pharma International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nafata 360 Pharma International's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nafata 360 Pharma International Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Nafata 360 Pharma International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The activity A charge registered on 20 Jul 2018 via Charge ID 100217405 with Canara Bank was fully satisfied on 03 Dec 2019. was completed.
A charge with Canara Bank amounted to Rs. 1.00 M with Charge ID 100217405 was registered on 20 Jul 2018. was recorded as a recent event.
The activity Nazarudeen Ebrahimkutty was appointed as a Director was appointed as a Director on 23 Jan 2018 & has been associated with this company since 7 years 10 months . was completed.
Fathahudeen was appointed as a Director was appointed as a Director on 23 Jan 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.
The CIN of Nafata 360 Pharma International Private Limited is U51909KL2018PTC051891.
Nafata 360 Pharma International Private Limited is headquartered at Shop No. 19/86, Al Jood Kottiyam Po, Kollam, Kerala, 691571.
Nafata 360 Pharma International Private Limited was incorporated on 23 January 2018.
The current directors of Nafata 360 Pharma International Private Limited are
The primary industry of Nafata 360 Pharma International Private Limited is Pharma.
Nafata 360 Pharma International Private Limited is unlisted.
The authorized capital of Nafata 360 Pharma International Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX